PARALYTIC LAGOPHTHALMOS

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting PARALYTIC LAGOPHTHALMOS:

# Drug Count
0 METHOTREXATE SODIUM 7
1 ATEZOLIZUMAB 6
2 BEVACIZUMAB 6
3 CARBOPLATIN 6
4 METHOTREXATE 6
5 OSIMERTINIB 6
6 PEMETREXED 6
7 PEMETREXED DISODIUM 6
8 ADALIMUMAB 2
9 PREDNISONE 2
See all common drugs associated with PARALYTIC LAGOPHTHALMOS

PARALYTIC LAGOPHTHALMOS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OXYMETAZOLINE HYDROCHLORIDE 1 0.0002
1 OSIMERTINIB 6 0.0002
2 TEPROTUMUMAB 1 0.0002
3 PEMETREXED DISODIUM 6 0.0002
4 CILTACABTAGENE AUTOLEUCEL 1 0.0002
5 ATEZOLIZUMAB 6 0.0002
6 EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE 1 0.0001
7 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 1 0.0001
8 BOTULINUM TOXIN TYPE A 1 0.0001
9 BEVACIZUMAB 6 0.0000
See all drugs enriched for association with PARALYTIC LAGOPHTHALMOS